Di/Oligomerization of GPCRs - Mechanisms and functional significance

Progress in Molecular Biology and Translational Science

Volumn 117, Issue , 2013, Pages 163-185

  Rivero Müller, Adolfo ^a   Jonas, Kim Carol ^b   Hanyaloglu, Aylin Carla ^b   Huhtaniemi, Ilpo ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Dimerization; Disease; Functional complementation; Functional rescue; GPCR; Oligomerization; Pharmacological diversity; Physiology; Signal transduction

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ANGIOTENSIN RECEPTOR; BETA ARRESTIN; CALCITONIN RECEPTOR LIKE RECEPTOR; CALCIUM SENSING RECEPTOR; DIMER; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; HETERODIMER; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN; THYROTROPIN RECEPTOR; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ALLOSTERISM; ANIMAL; ARTICLE; CAPPING PHENOMENON; CELLS; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATIONAL TRANSITION; DIMERIZATION; DISEASES; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; HEALTH; HUMAN; INTRACELLULAR SIGNALING; LIGAND BINDING; LIPID RAFT; METABOLISM; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MULTIMERIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 84896689290     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386931-9.00007-6     Document Type: Chapter

References (103)

1. J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 103 2000 211 225
2. A. Weiss, and J. Schlessinger Switching signals on or off by receptor dimerization Cell 94 1998 277 280
3. N.J.M. Birdsall Can different receptors interact directly with each other? Trends Neurosci 5 1982 137 138
4. A.M. Watanabe, M.M. McConnaughey, R.A. Strawbridge, J.W. Fleming, L.R. Jones, and H.R. Besch Jr. Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines J Biol Chem 253 1978 4833 4836
5. T.E. Hebert, S. Moffett, J.P. Morello, T.P. Loisel, D.G. Bichet, and C. Barret A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation J Biol Chem 271 1996 16384 16392
6. G.Y. Ng, B.F. O'Dowd, S.P. Lee, H.T. Chung, M.R. Brann, and P. Seeman Dopamine D2 receptor dimers and receptor-blocking peptides Biochem Biophys Res Commun 227 1996 200 204
7. C. Romano, W.L. Yang, and K.L. O'Malley Metabotropic glutamate receptor 5 is a disulfide-linked dimer J Biol Chem 271 1996 28612 28616
8. J.H. White, A. Wise, M.J. Main, A. Green, N.J. Fraser, and G.H. Disney Heterodimerization is required for the formation of a functional GABA(B) receptor Nature 396 1998 679 682
9. K.A. Jones, B. Borowsky, J.A. Tamm, D.A. Craig, M.M. Durkin, and M. Dai GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2 Nature 396 1998 674 679
10. K. Kaupmann, B. Malitschek, V. Schuler, J. Heid, W. Froestl, and P. Beck GABA(B)-receptor subtypes assemble into functional heteromeric complexes Nature 396 1998 683 687
11. B.A. Jordan, and L.A. Devi G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 1999 697 700
12. S. AbdAlla, H. Lother, and U. Quitterer AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration Nature 407 2000 94 98
13. J.R. James, M.I. Oliveira, A.M. Carmo, A. Iaboni, and S.J. Davis A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer Nat Methods 3 2006 1001 1006
14. M. Bouvier, N. Heveker, R. Jockers, S. Marullo, and G. Milligan BRET analysis of GPCR oligomerization: newer does not mean better Nat Methods 4 2007 3 4 author reply 4
15. A. Salahpour, and B. Masri Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization Nat Methods 4 2007 599 600 author reply 601
16. V.V. Gurevich, and E.V. Gurevich GPCR monomers and oligomers: it takes all kinds Trends Neurosci 31 2008 74 81
17. M.R. Whorton, M.P. Bokoch, S.G. Rasmussen, B. Huang, R.N. Zare, and B. Kobilka A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein Proc Natl Acad Sci USA 104 2007 7682 7687
18. T.H. Bayburt, S.A. Vishnivetskiy, M.A. McLean, T. Morizumi, C.C. Huang, and J.J. Tesmer Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding J Biol Chem 286 2010 1420 1428
19. R. Maggio, Z. Vogel, and J. Wess Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors Proc Natl Acad Sci USA 90 1993 3103 3107
20. C. Parnot, and B. Kobilka Toward understanding GPCR dimers Nat Struct Mol Biol 11 2004 691 692
21. S. Angers, A. Salahpour, E. Joly, S. Hilairet, D. Chelsky, and M. Dennis Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) Proc Natl Acad Sci USA 97 2000 3684 3689
22. M.C. Overton, and K.J. Blumer G-protein-coupled receptors function as oligomers in vivo Curr Biol 10 2000 341 344
23. M.J. Robbins, A.R. Calver, A.K. Filippov, W.D. Hirst, R.B. Russell, and M.D. Wood GABA(B2) is essential for g-protein coupling of the GABA(B) receptor heterodimer J Neurosci 21 2001 8043 8052
24. J.J. Carrillo, J. Pediani, and G. Milligan Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins J Biol Chem 278 2003 42578 42587
25. R.D. Horvat, B.G. Barisas, and D.A. Roess Luteinizing hormone receptors are self-associated in slowly diffusing complexes during receptor desensitization Mol Endocrinol 15 2001 534 542
26. S.M. Smith, Y. Lei, J. Liu, M.E. Cahill, G.M. Hagen, and B.G. Barisas Luteinizing hormone receptors translocate to plasma membrane microdomains after binding of human chorionic gonadotropin Endocrinology 147 2006 1789 1795
27. P.M. Conn, D.C. Rogers, J.M. Stewart, J. Niedel, and T. Sheffield Conversion of a gonadotropin-releasing hormone antagonist to an agonist Nature 296 1982 653 655
28. T.E. Hebert, T.P. Loisel, L. Adam, N. Ethier, S.S. Onge, and M. Bouvier Functional rescue of a constitutively desensitized beta2AR through receptor dimerization Biochem J 330 Pt 1 1998 287 293
29. H. Xu, L. Staszewski, H. Tang, E. Adler, M. Zoller, and X. Li Different functional roles of T1R subunits in the heteromeric taste receptors Proc Natl Acad Sci USA 101 2004 14258 14263
30. J.P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, and J.A. Javitch International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers Pharmacol Rev 59 2007 5 13
31. T. Okamoto, N. Sekiyama, M. Otsu, Y. Shimada, A. Sato, and S. Nakanishi Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1 J Biol Chem 273 1998 13089 13096
32. Y. Tsuji, Y. Shimada, T. Takeshita, N. Kajimura, S. Nomura, and N. Sekiyama Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1 J Biol Chem 275 2000 28144 28151
33. G. Han, and D.R. Hampson Ligand binding to the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor J Biol Chem 274 1999 10008 10013
34. P.K. Goldsmith, G.F. Fan, K. Ray, J. Shiloach, P. McPhie, and K.V. Rogers Expression, purification, and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor J Biol Chem 274 1999 11303 11309
35. N. Kunishima, Y. Shimada, Y. Tsuji, T. Sato, M. Yamamoto, and T. Kumasaka Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor Nature 407 2000 971 977
36. F. Novi, L. Stanasila, F. Giorgi, G.U. Corsini, S. Cotecchia, and R. Maggio Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane J Biol Chem 280 2005 19768 19776
37. E. Urizar, L. Montanelli, T. Loy, M. Bonomi, S. Swillens, and C. Gales Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity EMBO J 24 2005 1954 1964
38. J.P. Pin, L. Comps-Agrar, D. Maurel, C. Monnier, M.L. Rives, and E. Trinquet G-protein-coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors J Physiol 587 2009 5337 5344
39. I. Ji, C. Lee, M. Jeoung, Y. Koo, G.A. Sievert, and T.H. Ji Trans-activation of mutant follicle-stimulating hormone receptors selectively generates only one of two hormone signals Mol Endocrinol 18 2004 968 978
40. I. Ji, C. Lee, Y. Song, P.M. Conn, and T.H. Ji Cis- and trans-activation of hormone receptors: the LH receptor Mol Endocrinol 16 2002 1299 1308
41. C. Lee, I. Ji, K. Ryu, Y. Song, P.M. Conn, and T.H. Ji Two defective heterozygous luteinizing hormone receptors can rescue hormone action J Biol Chem 277 2002 15795 15800
42. C. Lee, I.J. Ji, and T.H. Ji Use of defined-function mutants to access receptor-receptor interactions Methods 27 2002 318 323
43. Y. Osuga, M. Hayashi, M. Kudo, M. Conti, B. Kobilka, and A.J. Hsueh Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation J Biol Chem 272 1997 25006 25012
44. Q.R. Fan, and W.A. Hendrickson Structure of human follicle-stimulating hormone in complex with its receptor Nature 433 2005 269 277
45. D.A. Roess, R.D. Horvat, H. Munnelly, and B.G. Barisas Luteinizing hormone receptors are self-associated in the plasma membrane Endocrinology 141 2000 4518 4523
46. B. Karges, S. Gidenne, C. Aumas, F. Haddad, P.A. Kelly, and E. Milgrom Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activation Mol Endocrinol 19 2005 2086 2098
47. G. Vassart, L. Pardo, and S. Costagliola A molecular dissection of the glycoprotein hormone receptors Trends Biochem Sci 29 2004 119 126
48. B.M. Binder, M.S. Biernbaum, and M.D. Bownds Light activation of one rhodopsin molecule causes the phosphorylation of hundreds of others. A reaction observed in electropermeabilized frog rod outer segments exposed to dim illumination J Biol Chem 265 1990 15333 15340
49. F. Huttenrauch, B. Pollok-Kopp, and M. Oppermann G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers J Biol Chem 280 2005 37503 37515
50. S. Terrillon, C. Barberis, and M. Bouvier Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns Proc Natl Acad Sci USA 101 2004 1548 1553
51. C.H. So, G. Varghese, K.J. Curley, M.M. Kong, M. Alijaniaram, and X. Ji D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptor Mol Pharmacol 68 2005 568 578
52. L.M. McLatchie, N.J. Fraser, M.J. Main, A. Wise, J. Brown, and N. Thompson RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 393 1998 333 339
53. L. Comps-Agrar, J. Kniazeff, L. Norskov-Lauritsen, D. Maurel, M. Gassmann, and N. Gregor The oligomeric state sets GABA(B) receptor signalling efficacy EMBO J 30 2011 2336 2349
54. J. Schwenk, M. Metz, G. Zolles, R. Turecek, T. Fritzius, and W. Bildl Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits Nature 465 2010 231 235
55. S. Laffray, R. Bouali-Benazzouz, M.A. Papon, A. Favereaux, Y. Jiang, and T. Holm Impairment of GABAB receptor dimer by endogenous 14-3-3zeta in chronic pain conditions EMBO J 31 2012 3239 3251
56. D.J. Daniels, N.R. Lenard, C.L. Etienne, P.Y. Law, S.C. Roerig, and P.S. Portoghese Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series Proc Natl Acad Sci USA 102 2005 19208 19213
57. R. Rozenfeld, A. Gupta, K. Gagnidze, M.P. Lim, I. Gomes, and D. Lee-Ramos AT1R-CB(1)R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II EMBO J 30 2011 2350 2363
58. I.T. Huhtaniemi, and A.P. Themmen Mutations in human gonadotropin and gonadotropin-receptor genes Endocrine 26 2005 207 217
59. Y. Zhang, F. Buchholz, J.P. Muyrers, and A.F. Stewart A new logic for DNA engineering using recombination in Escherichia coli Nat Genet 20 1998 123 128
60. F.P. Zhang, M. Poutanen, J. Wilbertz, and I. Huhtaniemi Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice Mol Endocrinol 15 2001 172 183
61. A. Rivero-Müller, Y.-Y. Chou, I. Ji, S. Lajic, A.C. Hanyaloglu, and K. Jonas Rescue of defective G protein-coupled receptor function in vivo by intermolecular co-operation Proc Natl Acad Sci USA 107 2010 2319 2324
62. D. Marcellino, S. Ferre, V. Casado, A. Cortes, B. Le Foll, and C. Mazzola Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum J Biol Chem 283 2008 26016 26025
63. J. Gonzalez-Maeso, N.V. Weisstaub, M. Zhou, P. Chan, L. Ivic, and R. Ang Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452
64. J.L. Moreno, T. Holloway, L. Albizu, S.C. Sealfon, and J. Gonzalez-Maeso Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists Neurosci Lett 493 2011 76 79
65. S. AbdAlla, H. Lother, A. El Massiery, and U. Quitterer Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness Nat Med 7 2001 1003 1009
66. L. Barki-Harrington, L.M. Luttrell, and H.A. Rockman Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo Circulation 108 2003 1611 1618
67. S.P. Brothers, A. Cornea, J.A. Janovick, and P.M. Conn Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect Mol Endocrinol 18 2004 1787 1797
68. D. Calebiro, T. de Filippis, S. Lucchi, C. Covino, S. Panigone, and P. Beck-Peccoz Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance Hum Mol Genet 14 2005 2991 3002
69. A.T. McElvaine, and K.E. Mayo A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding Endocrinology 147 2006 1884 1894
70. A. Leanos-Miranda, A. Ulloa-Aguirre, J.A. Janovick, and P.M. Conn In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles J Clin Endocrinol Metab 90 2005 3001 3008
71. J.A. Janovick, P.E. Knollman, S.P. Brothers, R. Ayala-Yanez, A.S. Aziz, and P.M. Conn Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy J Biol Chem 281 2006 8417 8425
72. P.M. Conn, and A. Ulloa-Aguirre Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs Trends Endocrinol Metab 21 2010 190 197
73. A. Ulloa-Aguirre, J.A. Janovick, S.P. Brothers, and P.M. Conn Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease Traffic 5 2004 821 837
74. C.L. Newton, A.M. Whay, C.A. McArdle, M. Zhang, C.J. van Koppen, and R. van de Lagemaat Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist Proc Natl Acad Sci USA 108 2011 7172 7176
75. N.A. Ward, S. Hirst, J. Williams, and J.B. Findlay Pharmacological chaperones increase the cell-surface expression of intracellularly retained mutants of the melanocortin 4 receptor with unique rescuing efficacy profiles Biochem Soc Trans 40 2012 717 720
76. P. Rene, C. Le Gouill, I.D. Pogozheva, G. Lee, H.I. Mosberg, and I.S. Farooqi Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity J Pharmacol Exp Ther 335 2010 520 532
77. S. Majumdar, S. Grinnell, V. Le Rouzic, M. Burgman, L. Polikar, and M. Ansonoff Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects Proc Natl Acad Sci USA 108 2011 19778 19783
78. P.K. Leung, K.B. Chow, P.N. Lau, K.M. Chu, C.B. Chan, and C.H. Cheng The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor Cell Signal 19 2007 1011 1022
79. K. Takahashi, C. Furukawa, A. Takano, N. Ishikawa, T. Kato, and S. Hayama The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer Cancer Res 66 2006 9408 9419
80. T. Kanda, M.J. Jackson, L.A. Smith, R.K. Pearce, J. Nakamura, and H. Kase Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys Ann Neurol 43 1998 507 513
81. K. Xu, E. Bastia, and M. Schwarzschild Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease Pharmacol Ther 105 2005 267 310
82. M.A. Schwarzschild, L. Agnati, K. Fuxe, J.F. Chen, and M. Morelli Targeting adenosine A2A receptors in Parkinson's disease Trends Neurosci 29 2006 647 654
83. M.A. Hoon, E. Adler, J. Lindemeier, J.F. Battey, N.J. Ryba, and C.S. Zuker Putative mammalian taste receptors: a class of taste-specific GPCRs with distinct topographic selectivity Cell 96 1999 541 551
84. G. Nelson, M.A. Hoon, J. Chandrashekar, Y. Zhang, N.J. Ryba, and C.S. Zuker Mammalian sweet taste receptors Cell 106 2001 381 390
85. E. Adler, M.A. Hoon, K.L. Mueller, J. Chandrashekar, N.J. Ryba, and C.S. Zuker A novel family of mammalian taste receptors Cell 100 2000 693 702
86. E.M. Neuhaus, G. Gisselmann, W. Zhang, R. Dooley, K. Stortkuhl, and H. Hatt Odorant receptor heterodimerization in the olfactory system of Drosophila melanogaster Nat Neurosci 8 2005 15 17
87. R. Benton, S. Sachse, S.W. Michnick, and L.B. Vosshall Atypical membrane topology and heteromeric function of Drosophila odorant receptors in vivo PLoS Biol 4 2006 e20
88. A. Levoye, J. Dam, M.A. Ayoub, J.L. Guillaume, C. Couturier, and P. Delagrange The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization EMBO J 25 2006 3012 3023
89. N.A. Riobo, K. Lu, and C.P. Emerson Jr. Hedgehog signal transduction: signal integration and cross talk in development and cancer Cell Cycle 5 2006 1612 1615
90. D.E. Gloriam, R. Fredriksson, and H.B. Schioth The G protein-coupled receptor subset of the rat genome BMC Genomics 8 2007 338
91. V.V. Gurevich, and E.V. Gurevich How and why do GPCRs dimerize? Trends Pharmacol Sci 29 2008 234 240
92. S. Angers, A. Salahpour, and M. Bouvier Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function Annu Rev Pharmacol Toxicol 42 2002 409 435
93. S. Terrillon, and M. Bouvier Roles of G-protein-coupled receptor dimerization EMBO Rep 5 2004 30 34
94. J. Gonzalez-Maeso GPCR oligomers in pharmacology and signaling Mol Brain 4 2011 20
95. K.K. Haack, M.R. Tougas, K.T. Jones, S.S. El-Dahr, H. Radhakrishna, and N.A. McCarty A novel bioassay for detecting GPCR heterodimerization: transactivation of beta 2 adrenergic receptor by bradykinin receptor J Biomol Screen 15 2010 251 260
96. J.A. Janovick, A. Ulloa-Aguirre, and P.M. Conn Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression Endocrine 22 2003 317 327
97. A. Ulloa-Aguirre, J.A. Janovick, A.L. Miranda, and P.M. Conn G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease ACS Chem Biol 1 2006 631 638
98. S.L. Ritter, and R.A. Hall Fine-tuning of GPCR activity by receptor-interacting proteins Nat Rev Mol Cell Biol 10 2009 819 830
99. G. Milligan G protein-coupled receptor dimerization: function and ligand pharmacology Mol Pharmacol 66 2004 1 7
100. M. Bai Dimerization of G-protein-coupled receptors: roles in signal transduction Cell Signal 16 2004 175 186
101. P.M. Conn, A. Ulloa-Aguirre, J. Ito, and J.A. Janovick G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo Pharmacol Rev 59 2007 225 250
102. A. Leanos-Miranda, A. Ulloa-Aguirre, T.H. Ji, J.A. Janovick, and P.M. Conn Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans J Clin Endocrinol Metab 88 2003 3360 3367
103. H. Wise The roles played by highly truncated splice variants of G protein-coupled receptors J Mol Signal 7 2012 13